Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Control of brain networks after traumatic brain injury: dopamine and cognition
2013-004244-37Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylphenidate in traumatic brain injury (TBI), sponsored by Imperial College London. Primary endpoint: Primary: improvement in choice reaction time with methylphenidate in relation to DAT VT. Started Dec 2013; status: completed.
02
Drugs
methylphenidate
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2013-004244-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004244-37.